LFVN officer amendment: 51,330 common shares, PRSU grants updated

Rhea-AI Filing Summary

LifeVantage (LFVN)51,330 shares and adds 16,491 performance RSUs granted on August 26, 2025. The original reported 40,336 shares and omitted this PRSU grant.

It also lists 3,750 PRSUs granted on December 23, 2024. Vesting for the 2024 grant: 50% on August 31, 2025; 30% on August 31, 2026; 20% on August 31, 2027, subject to performance and continued service. The 2025 grant vests 34% on September 10, 2026; 33% on September 10, 2027; and 33% on September 10, 2028. The amendment adds Exhibit 24, Power of Attorney.

10/15/2025 - 05:04 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Thompson Todd

(Last) (First) (Middle)

3300 N. TRIUMPH BLVD

SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/12/2025

3. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
10/03/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	51,330(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units(2)	(3)	(3)	Common Stock	3,750	(3)	D
Performance Restricted Stock Units(2)	(4)	(4)	Common Stock	16,491(1)	(4)	D

Explanation of Responses:

1. This Form 3/A is being filed to correct the number of shares of common stock and Performance Restricted Stock Units ("PRSU") reported in Tables I and II, respectively, of the original Form 3 filed on October 3, 2025. Table I inadvertently reported 40,336 shares of common stock beneficially owned by the reporting person instead of the 51,330 shares reported herein. Table II inadvertently omitted 16,491 PRSUs granted to the reporting person on August 26, 2025, reported herein.

2. Each PRSU represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.

3. The PRSUs were granted on December 23, 2024. The number reported reflects the unvested PRSUs remaining under such grant. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows (i) 50% of the earned award vested on August 31, 2025 (ii) 30% of the earned award will vest on August 31, 2026 and (iii) 20% of the earned award will vest on August 31, 2027.

4. The PRSUs were granted on August 26, 2025. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.

Remarks:

The Form 3 filed on October 3, 2025 is amended to include Exhibit 24 - Power of Attorney.

	/s/ Alissa Neufeld, Power of Attorney for Todd Thompson	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LifeVantage (LFVN) update in this Form 3/A?

It corrected the officer’s holdings to 51,330 common shares and added 16,491 PRSUs granted on August 26, 2025.

Who is the reporting person in LFVN’s Form 3/A amendment?

Todd Thompson, Chief Information Officer of LifeVantage.

What derivative awards are disclosed for LFVN’s officer?

Two PRSU grants: 3,750 (granted Dec 23, 2024) and 16,491 (granted Aug 26, 2025), each representing one share per unit at target.

What are the vesting schedules for the PRSUs?

2024 grant: 50% on Aug 31, 2025; 30% on Aug 31, 2026; 20% on Aug 31, 2027. 2025 grant: 34% on Sep 10, 2026; 33% on Sep 10, 2027; 33% on Sep 10, 2028, subject to performance and service.

Does the Form 3/A mention performance multipliers?

Yes. Upon maximum performance, the reporting person may earn up to 200% of the target number of PRSUs.

What additional exhibit was included in the amendment?

The filing adds Exhibit 24 – Power of Attorney.